Skip to content

Barbara Barbini

2 papers in the library · 3 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

Intravenous Ketamine Followed by Intranasal Esketamine in 2 Subsequent Treatment-resistant Depressive Episodes: Insights From a Case Series.

Journal of Psychiatric Practice September 1, 2025 Matteo Carminati, Mattia Tondello, Barbara Barbini et al. 2 citations

Treatment-resistant depression (TRD) remains a relevant issue in psychiatric practice, driving the exploration of innovative therapeutic alternatives. Ketamine and its enantiomer, esketamine, are emerging as treatments known for their effectiveness as rapid-acting antidepressants. Although previous comparative studies have highlighted some differences in their effects, they did not concurrently...